FDA Issues Complete Response Letter for Arena's Lorcaserin
This article was originally published in The Pink Sheet Daily
Executive Summary
Concerrns Raised by Advisory Committee Come Back to Haunt Lorcaserin, the company's first product to go through regulatory process.